Next report date
Report period
Q1 2024
EPS estimate
−0.35SEK
Revenue estimate
—
−6.540SEK
−215.81 MSEK
25.03 M
About SYNACT PHARMA AB
Sector
CEO
Jeppe Øvli Øvlesen
Headquarters
Lund
Website
Employees (FY)
5
Founded
2016
ISIN
SE0008241491
FIGI
BBG00CZP0DV6
SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. It also performs clinical development in order to secure proof-of-concept such as clinical relevance. The company was founded by Søren Nielsen on April 12, 2016 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SYNACT is 7.050 SEK — it has increased by 1.59% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange SYNACT PHARMA AB stocks are traded under the ticker SYNACT.
SYNACT PHARMA AB is going to release the next earnings report on May 17, 2024. Keep track of upcoming events with our Earnings Calendar.
SYNACT stock is 6.40% volatile and has beta coefficient of −0.33. Check out the list of the most volatile stocks — is SYNACT PHARMA AB there?
Yes, you can track SYNACT PHARMA AB financials in yearly and quarterly reports right on TradingView.
SYNACT stock has risen by 5.30% compared to the previous week, the month change is a 23.03% fall, over the last year SYNACT PHARMA AB has showed a 90.33% decrease.
SYNACT net income for the last quarter is −90.54 M SEK, while the quarter before that showed −31.88 M SEK of net income which accounts for −184.03% change. Track more SYNACT PHARMA AB financial stats to get the full picture.
Today SYNACT PHARMA AB has the market capitalization of 246.86 M, it has increased by 7.15% over the last week.
No, SYNACT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SYNACT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNACT PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 5.00 employees. See our rating of the largest employees — is SYNACT PHARMA AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNACT PHARMA AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNACT PHARMA AB stock shows the sell signal. See more of SYNACT PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SYNACT PHARMA AB future price: according to them, SYNACT price has a max estimate of 17.00 SEK and a min estimate of 17.00 SEK. Read a more detailed SYNACT PHARMA AB forecast: see what analysts think of SYNACT PHARMA AB and suggest that you do with its stocks.